| Dr Dominic Marino, DO | |
|
1075 Mason Ave, Daytona Beach, FL 32117-4611 | |
| (386) 255-4596 | |
| (386) 258-3561 |
| Full Name | Dr Dominic Marino |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 7 Years |
| Location | 1075 Mason Ave, Daytona Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225577703 | NPI | - | NPPES |
| 114003100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | OS18633 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Halifax Health Care At Home | Port orange, FL | Home health agency |
| Halifax Health Medical Center | Daytona beach, FL | Hospital |
| Adventhealth Daytona Beach | Daytona beach, FL | Hospital |
| Florida Hospital Flagler | Palm coast, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic Clinic Of Daytona Beach Pa | 9335123504 | 35 |
News Archive
Researchers at the University Hospital of Salzburg's EB House Austria are using a Tecan Spark multimode reader to investigate epidermolysis bullosa, a rare inherited disease that causes the skin to become ‘as fragile as a butterfly's wings', blistering in response to friction or trauma.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
The team lead by Sílvia Vilares Conde, from CEDOC-NOVA Medical School, in collaboration with the pharmaceutical company Galvani Bioelectronics, demonstrated through findings in rats that is possible to restore insulin sensitivity and glucose homeostasis, by modulating electrically the carotid sinus nerve, the sensitive nerve that connects the carotid body with the brain. The study is published in Diabetologia, the journal of the European Association for the Study of Diabetes.
Since 1980, the incidence of ductal carcinoma in situ, or DCIS, one of the most common kinds of early stage breast cancer, has increased more than sevenfold. This sharp increase in DCIS – which is a tumor that contains cancer-like cells but is not considered "true" cancer because the cells have not invaded normal breast tissue – has been accompanied by a flattening in the incidence of true invasive breast cancer.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 3 days ago
| Entity Name | Musculoskeletal Institute Chartered |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386639920 PECOS PAC ID: 1052224102 Enrollment ID: O20031106000215 |
News Archive
Researchers at the University Hospital of Salzburg's EB House Austria are using a Tecan Spark multimode reader to investigate epidermolysis bullosa, a rare inherited disease that causes the skin to become ‘as fragile as a butterfly's wings', blistering in response to friction or trauma.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
The team lead by Sílvia Vilares Conde, from CEDOC-NOVA Medical School, in collaboration with the pharmaceutical company Galvani Bioelectronics, demonstrated through findings in rats that is possible to restore insulin sensitivity and glucose homeostasis, by modulating electrically the carotid sinus nerve, the sensitive nerve that connects the carotid body with the brain. The study is published in Diabetologia, the journal of the European Association for the Study of Diabetes.
Since 1980, the incidence of ductal carcinoma in situ, or DCIS, one of the most common kinds of early stage breast cancer, has increased more than sevenfold. This sharp increase in DCIS – which is a tumor that contains cancer-like cells but is not considered "true" cancer because the cells have not invaded normal breast tissue – has been accompanied by a flattening in the incidence of true invasive breast cancer.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 3 days ago
| Entity Name | Orthopaedic Clinic Of Daytona Beach Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558340240 PECOS PAC ID: 9335123504 Enrollment ID: O20040615001416 |
News Archive
Researchers at the University Hospital of Salzburg's EB House Austria are using a Tecan Spark multimode reader to investigate epidermolysis bullosa, a rare inherited disease that causes the skin to become ‘as fragile as a butterfly's wings', blistering in response to friction or trauma.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
The team lead by Sílvia Vilares Conde, from CEDOC-NOVA Medical School, in collaboration with the pharmaceutical company Galvani Bioelectronics, demonstrated through findings in rats that is possible to restore insulin sensitivity and glucose homeostasis, by modulating electrically the carotid sinus nerve, the sensitive nerve that connects the carotid body with the brain. The study is published in Diabetologia, the journal of the European Association for the Study of Diabetes.
Since 1980, the incidence of ductal carcinoma in situ, or DCIS, one of the most common kinds of early stage breast cancer, has increased more than sevenfold. This sharp increase in DCIS – which is a tumor that contains cancer-like cells but is not considered "true" cancer because the cells have not invaded normal breast tissue – has been accompanied by a flattening in the incidence of true invasive breast cancer.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dominic Marino, DO 1075 Mason Ave, Daytona Beach, FL 32117-4611 Ph: (386) 255-4596 | Dr Dominic Marino, DO 1075 Mason Ave, Daytona Beach, FL 32117-4611 Ph: (386) 255-4596 |
News Archive
Researchers at the University Hospital of Salzburg's EB House Austria are using a Tecan Spark multimode reader to investigate epidermolysis bullosa, a rare inherited disease that causes the skin to become ‘as fragile as a butterfly's wings', blistering in response to friction or trauma.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
The team lead by Sílvia Vilares Conde, from CEDOC-NOVA Medical School, in collaboration with the pharmaceutical company Galvani Bioelectronics, demonstrated through findings in rats that is possible to restore insulin sensitivity and glucose homeostasis, by modulating electrically the carotid sinus nerve, the sensitive nerve that connects the carotid body with the brain. The study is published in Diabetologia, the journal of the European Association for the Study of Diabetes.
Since 1980, the incidence of ductal carcinoma in situ, or DCIS, one of the most common kinds of early stage breast cancer, has increased more than sevenfold. This sharp increase in DCIS – which is a tumor that contains cancer-like cells but is not considered "true" cancer because the cells have not invaded normal breast tissue – has been accompanied by a flattening in the incidence of true invasive breast cancer.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 3 days ago
Todd A. Mccall, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1075 Mason Ave, Daytona Beach, FL 32117 Phone: 386-255-4596 Fax: 386-258-3561 | |
Dr. Scott Ian Silas, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 545 Health Blvd, Daytona Beach, FL 32114 Phone: 386-274-5252 Fax: 386-274-5544 | |
Mark C. Gillespy, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1075 Mason Ave, Daytona Beach, FL 32117 Phone: 386-255-4596 Fax: 386-258-3561 | |
Brian R. Hatten, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1075 Mason Ave, Daytona Beach, FL 32117 Phone: 386-255-4596 Fax: 386-258-3561 | |
Dr. Mark Richard Zunkiewicz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 305 Memorial Medical Pkwy Ste 206, Daytona Beach, FL 32117 Phone: 386-231-4450 Fax: 386-231-4459 | |
Mr. Srinivasa Sridhar, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 Memorial Medical Pkwy, Daytona Beach, FL 32117 Phone: 386-231-3346 Fax: 386-231-3357 |